Infectious Diseases News and Research

RSS

How can we define early COVID-19 reinfections?

In a new study, researchers investigated coronavirus disease 2019 reinfections.

11 Jul 2022

How does the belief that vaccination will end the COVID-19 pandemic relate to vaccination intent?

Researchers explored the intent and belief in COVID-19 vaccination in the Netherlands.

11 Jul 2022

Researchers discover the first effective drug to treat rare, genetic liver disease

Researchers at Saint Louis University's School of Medicine, in collaboration with Arrowhead Pharmaceuticals and Takeda Pharmaceuticals, report the first effective drug to treat a rare, genetic liver disease that formerly could only be treated with a liver transplant.

8 Jul 2022

Universal influenza B vaccine confers robust and sustained cross-immune protection

A new universal flu vaccine protects against influenza B viruses, offering broad defense against different strains and improved immune protection, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

8 Jul 2022

Research assesses antigenic co-evolution of SARS-CoV-2 variants

In a recent study posted to the bioRxiv* preprint server, researchers analyzed antigenic variety across the significant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, like Omicron lineages.

8 Jul 2022

Antibodies transmitted through breast milk persist six months after COVID mRNA vaccination

Researchers describe the effects of COVID-19 vaccines in lactating mothers and relates their antibody response to the protection of their children.

7 Jul 2022

Human milk immune activity may both lower and increase infants’ infectious disease risk

Researchers discuss the short-term effects of the immune system of breast milk on infant health.

7 Jul 2022

Researchers unravel mechanism that underlies failure of staph vaccine trials

For the most part, the bacterium Staphylococcus aureus is common and harmless, posing no threat to humans with whom they coexist.

7 Jul 2022

Novel COVID-19 antibody delivery approach advances to clinical trials

Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) funded program, a novel COVID-19 antibody delivery approach has advanced to clinical trials.

7 Jul 2022

Household overcrowding found to be a major risk factor for acute rheumatic fever and strep skin

Research led by the University of Otago in New Zealand has uncovered the strongest evidence yet that household overcrowding is a major risk factor for acute rheumatic fever and streptococcal infections of the skin.

7 Jul 2022

2022 monkeypox presents with new symptoms

In a recent study published in The Lancet Infectious Diseases, researchers described the clinical and demographical characteristics of monkeypox virus infections among individuals attending sexual health centers in the United Kingdom (UK).

6 Jul 2022

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system's history with other coronaviruses, including those behind the common cold, shapes the patient's response, according to a study published today in Cell Reports.

6 Jul 2022

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

DZNE and Intravacc B.V., a world leading contract development and manufacturing organization (CDMO) of preventive and therapeutic vaccines, have been awarded a funding of € 2.5 million from the European Union (EIC Transition Grant) to further develop a prototype ALS vaccine, including process development, scale-up, and toxicology study.

6 Jul 2022

Outpatient antibiotic management of patients with appendicitis is safe, helps avoid surgery

Outpatient antibiotic management of selected patients with appendicitis is safe, allowing many patients to avoid surgery and hospitalization, and should be considered as part of shared decision-making between doctor and patient.

6 Jul 2022

Beyond COVID-19: the potential future applications of mRNA vaccines

Researchers described the production, mechanisms, and potential applications of mRNA vaccines.

6 Jul 2022

Next-generation SARS-CoV-2 nucleocapsid-based vaccines may provide optimal protection against infection

In a new study,researchers suggested the inclusion of nucleocapsid protein in vaccines against SARS-CoV-2.

5 Jul 2022

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

The viral replication cycle is crucial for a virus to spread inside the body and cause disease. Focusing on that cycle in the hepatitis A virus (HAV), UNC School of Medicine scientists discovered that replication requires specific interactions between the human protein ZCCHC14 and a group of enzymes called TENT4 poly(A) polymerases.

4 Jul 2022

Infectious Diseases News and Research

How can we define early COVID-19 reinfections?

How does the belief that vaccination will end the COVID-19 pandemic relate to vaccination intent?

Researchers discover the first effective drug to treat rare, genetic liver disease

Universal influenza B vaccine confers robust and sustained cross-immune protection

Research assesses antigenic co-evolution of SARS-CoV-2 variants

Antibodies transmitted through breast milk persist six months after COVID mRNA vaccination

Human milk immune activity may both lower and increase infants’ infectious disease risk

Researchers unravel mechanism that underlies failure of staph vaccine trials

Novel COVID-19 antibody delivery approach advances to clinical trials

Household overcrowding found to be a major risk factor for acute rheumatic fever and strep skin

2022 monkeypox presents with new symptoms

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

DZNE and Intravacc receive € 2.5 million EU funding to develop a prototype ALS vaccine

Outpatient antibiotic management of patients with appendicitis is safe, helps avoid surgery

Beyond COVID-19: the potential future applications of mRNA vaccines

Next-generation SARS-CoV-2 nucleocapsid-based vaccines may provide optimal protection against infection

Scientists discover how a protein and enzymes interact to allow hepatitis A virus replication

How does obesity affect the immune system?

Generation of live attenuated influenza A virus vaccine using PROTAC technology

Two-step synthesis procedure produces amino acid Schiff base Cu (II) complexes within 10 minutes

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News